Company / Operating Margin
LIPELLA PHARMACEUTICALS INC. Operating Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-947.2%
FY2024
5-year range
-1406.3% / -947.2%
FY2022-FY2024
Trend
+10.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -1406.3% to -947.2% over the past 2 years.
Based on SEC 10-K filings.
-947.2% in FY2024.
Improved from -1406.3% to -947.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin increased 10.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -947.2% | +10.3% |
| FY2023 | -1055.5% | +24.9% |
| FY2022 | -1406.3% | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 29, 2026